Orca Bio

#TeamOrcaBio had a great time in San Diego at #ASH24! We connected with clinicians and industry leaders on the latest developments in #bloodcancer, and “unpacked” new positive data on Orca-T and Orca-Q, our investigational allogeneic T-cell immunotherapies. #celltherapy #oncology #hematology

We are pleased to present new clinical data on our investigational high-precision #celltherapies, Orca-T and Orca-Q, at the American Society of Hematology (ASH) Annual Meeting.   Check out our press releases for more information:  ➡️ Orca-T: https://bit.ly/3ZGI16T ➡️ Orca-Q: https://bit.ly/3D0ekVm #ASH24 #celltherapy #bloodcancer #oncology #hematology #celltherapy 

We will be sharing new clinical data from our investigational cell therapies, Orca-T and Orca-Q, at #ASH24. We’re excited to connect with other experts and discuss the latest advances in #celltherapy and #hematology. View our latest press release for details on our three oral presentations: https://bit.ly/4f9E6ok And don’t forget to stop by our booth #327! #bloodcancer #oncology #hematology #celltherapy

Today and every day, we are incredibly grateful for #TeamOrcaBio. Our employees bring an inspiring level of dedication to work each day as together we strive to make the world a better place for patients and the people who love them.

#ICYMI, Orca Bio’s Chief Commercial Officer, Dan Kirby, spoke at Fierce Life Sciences Events “Advanced Therapies: Cell & Gene, mRNA and Beyond” alongside leaders from Legend Biotech, MeiraGTx and City of Hope. The panelists discussed the challenges facing the cell and gene therapy field today, and how the industry can work together to ensure access for patients in the future. You can now view the session on demand here: https://bit.ly/4eCpWuY #celltherapy #oncology #hematology

We are thrilled to be named one of the “Top 100 Healthcare Technology Companies of 2024” by The Healthcare Technology Report! This recognition celebrates companies at the forefront of science and technology, and we are honored to be included for our efforts to advance high-precision cell therapies for patients with blood cancers. To read more: https://bit.ly/4ey0dnm #celltherapy #top100healthcaretech #biotech #healthtech

Next week, Katie Chaddock, Orca Bio's Site Head of Commercial Manufacturing, will be speaking at the Biomanufacturing World Summit in San Diego. Join Katie for a discussion around overcoming challenges to drive large-scale #manufacturing of #celltherapies. Learn more: https://bit.ly/48iq8xZ #BMWS2024

This week, Orca Bio’s Chief Commercial Officer, Dan Kirby, participated in the opening plenary panel at Terrapinn Advanced Therapies USA in Philadelphia. Titled “Cell & Gene, State of the Industry Address,” the panel brought together industry leaders to discuss the future of cell and gene therapy and the importance of collaboration and continued improvement to ensure broad patient access to life-saving treatments. #celltherapy #patientsfirst #oncology #hematology

We are pleased to announce that Orca Bio will present new clinical data on our investigational high-precision cell therapies, Orca-T and Orca-Q, at the 66th American Society of Hematology Annual Meeting in San Diego, CA. More on our #ASH24 presentations can be found here: https://bit.ly/4f9E6ok #bloodcancer #oncology #hematology #celltherapy

Today marks the start of #NationalMarrowAwarenessMonth, a time to honor those who donate stem cells and bone marrow to give patients a second chance at life. We also recognize the providers and researchers working tirelessly to help treat patients battling blood cancer. This month, we encourage everyone to consider joining the NMDP registry to potentially save a life. Thank you those who already have, we couldn’t do our work without you. To learn more: https://bit.ly/40DRACk #oncology #hematology #bloodcancer